For more than three decades, NordicNeuroLab has been dedicated to advancing neuroimaging through innovation, quality and close collaboration with the clinical and research communities. The company is entering a new phase of growth supported by strategic investors who share its long-term vision. “Their confidence reinforces our ability to expand our technological capabilities, accelerate research and development, and strengthen our global presence,” says NordicNeuroLab. “This renewed momentum enables us to transform ideas into practical tools that generate meaningful ‘rays of knowledge’ for healthcare professionals worldwide.”
With expertise in functional MRI, the company says it continues to set benchmarks through advanced fMRI paradigms, stimulation systems and integrated solutions for clinical and research applications. Its portfolio supports the acquisition of high quality data while enabling accurate and efficient analysis. Central to this is the nordicMediva post-processing software platform, which is being prepared for its official introduction to the European market, with CE marking expected within the year. nordicMediva combines advanced analytics, streamlined workflows and intuitive design, to help clinicians extract deeper insights from complex imaging data. “Equally important is our strong focus on the patient experience,” the company continues. “nordicComfortSolution puts comfort, safety and emotional wellbeing at the centre of every examination.”
Visit NordicNeuroLab at ECR on Stand 421, X4.
This news story has been sponsored by the companies concerned and does not represent the views or opinions of RAD Magazine. Visit our dedicated ECR conference page to find out more.
